Key Findings:  This article provides a discussion of a discussion of diverse gastrointestinal (GI) disorders, including the emergence of cannabis hyperemesis syndrome, and the available therapeutic strategies to manage symptoms and improve quality of life.
Type of Study:  Meta-analysis
Study Result:  Inconclusive
Research Location(s):  United States
Year of Pub:  2024
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Not Applicable
Citation:  McFee RB. Gastrointestinal disorders - Clinical challenges for the primary care clinician. Dis Mon. 2024 Dec;70(12):101828. doi: 10.1016/j.disamonth.2024.101828. Epub 2024 Dec 3. PMID: 39627098.